Skip to main content
Log in

Upper age limits in studies submitted to a research ethics committee

  • Original Articles
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims: Discrimination in research of new drugs for older people is frequent. We examined research protocols submitted to a research ethics committee, to ascertain whether they stipulated unjustified upper age limits, and whether these age limits are changing in time. Methods: Systematic review of protocols of studies submitted to the Research Ethics Committee of a public university hospital, in four different years, looking for unjustified upper age limits. Studies that dealt with topics or conditions that automatically excluded older people were not examined. Results: In the first three cohorts of protocols of intervention studies (1994, 1999, 2004), 36% to 40% stipulated an upper age limit. In 2007, only 19% of the protocols showed an unjustified limit. Non-intervention trials rarely had upper age limits. Age limits were arbitrarily chosen (65, 70, 75 or 80 years were chosen as cut-off points in most cases). Five to 6% of the protocols specifically concerned older persons, with no change in time. Conclusions: Unjustified age limits are frequent in the protocols of intervention studies, although the numbers have been falling recently. Ethics research committees are in a strong position to influence research practice and to reduce unethical age discrimination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bowling A. Ageism in cardiology. BMJ 1999; 319: 1353–5.

    Article  CAS  PubMed  Google Scholar 

  2. Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ 1997; 315: 1059.

    Article  CAS  PubMed  Google Scholar 

  3. Bartlett C, Doyal L, Ebrahim S et al. The causes and effects of socio-demographic exclusions from clinical trials. Health Technol Assess 2005; 9: iii–iv, ix–x, 1–152.

    CAS  PubMed  Google Scholar 

  4. Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ 2000; 321: 992–3.

    Article  CAS  PubMed  Google Scholar 

  5. Cruz-Jentoft AJ, Gutiérrez B. Unjustified exclusion of elderly people from clinical research. J Nutr Health Aging 2001; 5 (Suppl): 20 (Abstract).

    Google Scholar 

  6. European Medicines Agency (EMEA). Note for Guidance on Studies in Support of Special Populations: Geriatrics (online). Available at: http://www.emea.europa.eu/pdfs/human/ich/037995en.pdf. Accessed March 21, 2010.

  7. European Medicines Agency Committee for Human Medicinal Products (CHMP). Adequacy of Guidance on the Elderly regarding Medicinal Products for Human Use. EMEA/498920/2006 (online). Available at:http://www.emea.europa.eu/pdfs/human/opiniongen/49892006en.pdf. Accessed March 21, 2010.

  8. Habicht DW, Witham MD, McMurdo ME. The under-representation of older people in clinical trials: barriers and potential solutions. J Nutr Health Aging 2008; 12: 194–6.

    Article  CAS  PubMed  Google Scholar 

  9. Van Spall HG, Toren A, Kiss A et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007; 297: 1233–40.

    Article  PubMed  Google Scholar 

  10. Avom J. Including elderly people in clinical trials. BMJ 1997; 315: 1033–4.

    Article  Google Scholar 

  11. Godlovitch G. Age discrimination in trials and treatment: old dogs and new tricks. Monash Bioeth Rev 2003; 22: 66–77.

    PubMed  Google Scholar 

  12. Le Quintrec JL, Bussy C, Golmard JL et al. Randomized controlled drug trials on very elderly subjects: descriptive and methodological analysis of trials published between 1990 and 2002 and comparison with trials on adults. J Gerontol A Biol Sci Med Sci 2005; 60: 340–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfonso J. Cruz-Jentoft.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cruz-Jentoft, A.J., Gutiérrez, B. Upper age limits in studies submitted to a research ethics committee. Aging Clin Exp Res 22, 175–178 (2010). https://doi.org/10.1007/BF03324793

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324793

Keywords

Navigation